Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Antonini

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Anaesthesia|January 11, 2024
Reducing the carbon footprint of general anaesthesia: a comparison of total intravenous anaesthesia vs. a mixed anaesthetic strategy in 47,157 adult patientsM Bernat, A Boyer, M Roche, et al.
Mutation Research|November 14, 2013
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatinLieke H van Huis-Tanja, Dina M Kweekel, Xiaobo Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicityJ Tol, M Koopman, C J Rodenburg, et al.
Investigational New Drugs|March 13, 2008
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforationJ Tol, A Cats, L Mol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III studyM Koopman, N F Antonini, J Douma, et al.
Heart (British Cardiac Society)|March 18, 2005
Right ventricular functional recovery after acute myocardial infarction: relation with left ventricular function and interventricular septum motion. GISSI-3 echo substudyB A Popescu, F Antonini-Canterin, P L Temporelli, et al.
Heart (British Cardiac Society)|July 16, 2002
Relation between early mitral regurgitation and left ventricular thrombus formation after acute myocardial infarction: results of the GISSI-3 echo substudyL Ascione, F Antonini-Canterin, F Macor, et al.
Lancet (London, England)|July 17, 2007
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialMiriam Koopman, Ninja F Antonini, Joep Douma, et al.
The New England Journal of Medicine|February 7, 2009
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancerJolien Tol, Miriam Koopman, Annemieke Cats, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Anaesthesia|January 11, 2024
Reducing the carbon footprint of general anaesthesia: a comparison of total intravenous anaesthesia vs. a mixed anaesthetic strategy in 47,157 adult patientsM Bernat, A Boyer, M Roche, et al.
Mutation Research|November 14, 2013
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatinLieke H van Huis-Tanja, Dina M Kweekel, Xiaobo Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicityJ Tol, M Koopman, C J Rodenburg, et al.
Investigational New Drugs|March 13, 2008
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforationJ Tol, A Cats, L Mol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III studyM Koopman, N F Antonini, J Douma, et al.
Heart (British Cardiac Society)|March 18, 2005
Right ventricular functional recovery after acute myocardial infarction: relation with left ventricular function and interventricular septum motion. GISSI-3 echo substudyB A Popescu, F Antonini-Canterin, P L Temporelli, et al.
Heart (British Cardiac Society)|July 16, 2002
Relation between early mitral regurgitation and left ventricular thrombus formation after acute myocardial infarction: results of the GISSI-3 echo substudyL Ascione, F Antonini-Canterin, F Macor, et al.
Lancet (London, England)|July 17, 2007
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialMiriam Koopman, Ninja F Antonini, Joep Douma, et al.
The New England Journal of Medicine|February 7, 2009
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancerJolien Tol, Miriam Koopman, Annemieke Cats, et al.
Pageof 7